Keith A. Goldan - Dec 1, 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Stock symbol
SNDX
Transactions as of
Dec 1, 2025
Transactions value $
$0
Form type
4
Date filed
12/1/2025, 04:30 PM
Previous filing
Aug 7, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Goldan Keith A. Chief Financial Officer 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 2025-12-01 0001495411

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Gift $0 -1.22K -1.31% $0.00 92.5K Dec 1, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.